Literature DB >> 32600897

Overview of primary adult retroperitoneal tumours.

Luca Improta1, Dimitri Tzanis2, Toufik Bouhadiba3, Khoubeyb Abdelhafidh4, Sylvie Bonvalot5.   

Abstract

In front of a primary retroperitoneal tumour, it is necessary to have in mind all possible diagnoses in order to specify the diagnostic strategy and the treatment. According to the World Health Organization (WHO) classification of tumours, mesenchymal benign and malignant tumours (including sarcomas and, currently, neurogenic tumours), parasympathetic tumours, extragonadal germ cell tumours, and lymphoid tumours have been identified. By definition, primary retroperitoneal tumours start independently from the retroperitoneal organs. Secondary lesions, carcinoma metastasis, and adenopathy are excluded from this definition, but they can also develop in the retroperitoneal space and lead to misdiagnoses. In the absence of positive tumour markers or an evocative biology, percutaneous biopsy is necessary. Pathological diagnosis is necessary to decide whether surgery must be done, its timing among the other treatments, and its extension. This paper summarizes all the diagnostic possibilities.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Diagnosis; Retroperitoneal sarcoma; Retroperitoneal tumour; Surgery

Year:  2020        PMID: 32600897     DOI: 10.1016/j.ejso.2020.04.054

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Clinical Experience and Management Strategy of Retroperitoneal Tumor With Venous Tumor Thrombus Involvement.

Authors:  Zhuo Liu; Liyuan Ge; Lei Liu; Xun Zhao; Kewei Chen; Yuxuan Li; Abudureyimujiang Aili; Min Lu; Xinlong Pei; Dengyang Han; Shudong Zhang; Lulin Ma
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

2.  Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen-Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma.

Authors:  Guo-Qiang Xue; Cheng-Peng Li; Ang Lv; Xiu-Yun Tian; Jian-Hui Wu; Hui Qiu; Chun-Yi Hao
Journal:  Cancer Manag Res       Date:  2021-08-06       Impact factor: 3.989

3.  Two Different Types of Sarcoma Occurring Synchronously: The Impact of Molecular Biology on Therapeutic Strategy.

Authors:  Rabih Mikhael; Giovanni B Damiani; Toufik Bouhadiba; Dimitri Tzanis; Sylvie Bonvalot
Journal:  Cureus       Date:  2022-01-26

4.  An Analysis of Computed Tomography Imaging Features and Predictive Factors for Postoperative Recurrence and Metastasis of Abdominal Paragangliomas.

Authors:  Bailing Dai; Jie He; Xiandi Zhu; Zongyu Xie; Cui Zhang; Xiaoli Zhou; Zhao Yang; Jian Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-02-21       Impact factor: 3.161

5.  Transcriptome analysis of tumor-derived mesenchymal progenitor cells shows that CHST15 is a fibrosis regulator of retroperitoneal liposarcoma.

Authors:  Yang Sun; Fengjun Xiao; Huiyan Sun; Lin Zhang; Weida Chen; Li Du; Chengfeng Sun; Weiyuan Zhang; Qinqin Xu; Chengli Miao; Lisheng Wang
Journal:  Ann Transl Med       Date:  2022-03

6.  Challenging surgical treatment of giant retroperitoneal liposarcoma: A case report.

Authors:  Xiaoyi Wei; Yujie Qin; Song Ouyang; Jun Qian; Song Tu; Jiaxi Yao
Journal:  Oncol Lett       Date:  2022-07-15       Impact factor: 3.111

7.  Giant retroperitoneal lymphangioma in a 70-year-old male: a case report.

Authors:  Aymen Mabrouk; Farouk Ennaceur; Yasser Karoui; Eya Ben Nejma; Laila Jedidi; Mounir Ben Moussa
Journal:  Pan Afr Med J       Date:  2022-06-24

8.  Microsurgical treatment of lumbar paravertebral tumors via lateral retroperitoneal approach: operative technique and a series of 6 patients.

Authors:  Lei Zhang; Shichao Chen; Kai Wang; Hao Wu
Journal:  BMC Surg       Date:  2022-08-27       Impact factor: 2.030

9.  Reconstruction of three-dimensional models for complex female pelvic tumors.

Authors:  Yingwei Liu; Shenglan Meng; Miao Wei; Fengqin Dai; Lin Xiao; Xiaoling Mu; Junying Tang
Journal:  Int J Gynaecol Obstet       Date:  2022-02-22       Impact factor: 4.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.